{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:15:59Z","timestamp":1758042959952,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Medullary carcinoma of the colon (MCC) is a rare, evolving subtype of colorectal cancer that is histologically and clinically distinct from poorly differentiated and undifferentiated adenocarcinoma. Comprehensive meta-analyses show that MCCs predominantly have a mismatch repair-deficient (MMRd) phenotype, which typically predicts a more favourable prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case Presentation<\/jats:title>\n            <jats:p>We present a unique case involving a male patient with an aggressive presentation of\u00a0colon cancer. Histopathology supported a diagnosis of MCC,\u00a0initially staged as T3N0M0. Shortly after resection, the patient presented with rapidly progressing metastatic disease involving brain and subcutaneous metastases and subsequent mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>MCC is an understudied subpopulation of colon cancers. Historically, the presence of MMRd in early-stage colon cancer predicts a favourable prognosis and also a lack of benefit from adjuvant chemotherapy. Whether this also extrapolates to MCCs remains unclear, and as such, the case presented highlights the uncertainty in the current evidence base. Further research is warranted to help inform robust clinical management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s12029-025-01304-x","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:15:26Z","timestamp":1757625326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medullary Carcinoma of the Colon: Not as Favourable as Previously Thought?"],"prefix":"10.1007","volume":"56","author":[{"given":"Daniel","family":"Netto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mugtaba","family":"Dafalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haithum","family":"Tumeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Sowerby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Kamposioras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"issue":"8","key":"1304_CR1","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1200\/JCO.1999.17.8.2429","volume":"17","author":"G Lanza","year":"1999","unstructured":"Lanza G, Gafa R, Matteuzzi M, Santini A. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival. J Clin Oncol. 1999;17(8):2429.","journal-title":"J Clin Oncol"},{"key":"1304_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.humpath.2016.02.018","volume":"53","author":"J-S Pyo","year":"2016","unstructured":"Jung-Soo, P., JINHEE, S. , Guhyun, K. Medullary carcinoma in the colorectum: a systematic review and meta-analysis. Hum Pathol. 2016;53:91\u20136.","journal-title":"Hum Pathol"},{"issue":"1","key":"1304_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61354-2","volume":"14","author":"L Yang","year":"2024","unstructured":"Yang L, Yu L, Zhou Q, Liu L, Shen N, Li N. Risk factor analysis and nomogram development and verification for medullary carcinoma of the colon using SEER database. Sci Rep. 2024;14(1): 11426.","journal-title":"Sci Rep"},{"key":"1304_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2022.101856","volume":"45","author":"IS Jabbal","year":"2022","unstructured":"Jabbal IS, Nagarajan A, Rivera C, Yaghi M, Liang H, Nahleh Z, Bejarano P, Berho M, Wexner S. Medullary carcinoma of the colon: a comprehensive analysis of the National Cancer Database. Surg Oncol. 2022;45: 101856.","journal-title":"Surg Oncol"},{"issue":"5","key":"1304_CR5","first-page":"1815","volume":"150","author":"J Ruschoff","year":"1997","unstructured":"Ruschoff J, Dietmaier W, Luttges J, Seitz G, Bocker T, Zirngibl H, Schlegel J, Schackert HK, Jauch KW, Hofstaedter F. Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol. 1997;150(5):1815\u201325.","journal-title":"Am J Pathol"},{"key":"1304_CR6","volume-title":"Pathology and genetics of tumours of the digestive system","author":"SR Hamilton","year":"2000","unstructured":"Hamilton SR, Aaltonen LA. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000."},{"key":"1304_CR7","doi-asserted-by":"crossref","unstructured":"Thirunavukarasu P, Sathaiah M, Singla S, Sukumar S, Karunamurthy A, Pragatheeshwar KD, Lee KKW, Zeh H, Kane KM, Bartlett DL (2010) Medullary carcinoma of the large intestine: a population based analysis.\u00a0Int J Oncol\u00a037(4):901\u20137.","DOI":"10.3892\/ijo_00000741"},{"issue":"5","key":"1304_CR8","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/modpathol.2016.54","volume":"29","author":"K Friedman","year":"2016","unstructured":"Friedman K, Brodsky AS, Lu S, Wood S, Gill AJ, Lombardo K, Yang D, Resnick MB. Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment. Mod Pathol. 2016;29(5):528\u201341.","journal-title":"Mod Pathol"},{"issue":"20","key":"1304_CR9","doi-asserted-by":"publisher","first-page":"6099","DOI":"10.1111\/febs.16086","volume":"289","author":"MT Pallotta","year":"2022","unstructured":"Pallotta MT, Rossini S, Suvieri C, Coletti A, Orabona C, Macchiarulo A, Volpi C, Grohmann U. Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme. FEBS J. 2022;289(20):6099\u2013118.","journal-title":"FEBS J"},{"key":"1304_CR10","doi-asserted-by":"crossref","unstructured":"Fatima Z, Sharma P, Youssef B, Krishnan K (2021) Medullary carcinoma of the colon: a histopathologic challenge.\u00a0Cur\u0113us\u00a013(6):e15831.","DOI":"10.7759\/cureus.15831"},{"key":"1304_CR11","doi-asserted-by":"crossref","unstructured":"Winn B, Tavares R, Fanion J, Noble L, Gao J, Sabo E, Resnick MB (2009) Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation.\u00a0Human Pathol 40(3):398\u2013404.","DOI":"10.1016\/j.humpath.2008.08.014"},{"issue":"8","key":"1304_CR12","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.5858\/arpa.2013-0452-OA","volume":"138","author":"F Lin","year":"2014","unstructured":"Lin F, Shi J, Zhu S, Chen Z, Li A, Chen T, Wang HL, Liu H. Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine. Arch Pathol Lab Med. 2014;138(8):1015\u201326.","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"1304_CR13","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1200\/JCO.2010.30.1366","volume":"29","author":"G Hutchins","year":"2011","unstructured":"Hutchins G, Southward K, Gray R, Quirke P, Handley K, Magill L, Beaumont C, Stahlschmidt J, Richman S, Chambers P, Seymour M, Kerr D. Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol. 2011;29(10):1261\u201370.","journal-title":"J Clin Oncol"},{"key":"1304_CR14","doi-asserted-by":"crossref","unstructured":"Pag\u00e8s F, Mlecnik B, Marliot F, Bindea G, Ou F, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-B\u00f6rger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Gr\u00fctzmann R, Van Den Eynde M, Jouret-Mourin A, Kartheuser A, L\u00e9onard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, Macgregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, Van De Water C, Van Lent-Van Vliet S, Knijn N, Mu\u0219in\u0103 A, Scripcariu D, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon J (2018) International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study.\u00a0The Lancet (British edition)\u00a0391(10135):2128\u201339.","DOI":"10.1016\/S0140-6736(18)30789-X"},{"issue":"1","key":"1304_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/cam4.1921","volume":"8","author":"G Sun","year":"2019","unstructured":"Sun G, Dong X, Tang X, Qu H, Zhang H, Zhao E. The prognostic value of Immunoscore in patients with colorectal cancer: a systematic review and meta-analysis. Cancer Med. 2019;8(1):182\u20139.","journal-title":"Cancer Med"},{"issue":"4","key":"1304_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/jnci\/djab190","volume":"114","author":"V Formica","year":"2022","unstructured":"Formica V, Sera F, Cremolini C, Riondino S, Morelli C, Arkenau H, Roselli M. KRAS and BRAF mutations in stage II and III colon cancer: a systematic review and meta-analysis. JNCI J Natl Cancer Inst. 2022;114(4):517\u201327.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"8","key":"1304_CR17","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1200\/JCO.21.02538","volume":"40","author":"NN Baxter","year":"2022","unstructured":"Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, Gold PJ, Hantel A, Jones L, Lieu C, Mahmoud N, Morris AM, Ruiz-Garcia E, You YN, Meyerhardt JA. Adjuvant therapy for stage II colon cancer: ASCO guideline update. J Clin Oncol. 2022;40(8):892\u2013910.","journal-title":"J Clin Oncol"},{"issue":"20","key":"1304_CR18","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1200\/JCO.2009.27.1825","volume":"28","author":"DJ Sargent","year":"2010","unstructured":"Sargent DJ, Marsoni S, Ribic C, Grothey A, Moore M, Zaniboni A, Seitz J, Sinicrope F, Gallinger S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, French AJ, Kabat B, Foster NR, Torri V. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. J Clin Oncol. 2010;28(20):3219\u201326.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1304_CR19","first-page":"311","volume":"28","author":"J Cunningham","year":"2014","unstructured":"Cunningham J, Kantekure K, Saif MW. Medullary carcinoma of the colon: a case series and review of the literature. In vivo (Athens). 2014;28(3):311\u20134.","journal-title":"In vivo (Athens)"},{"issue":"2020","key":"1304_CR20","first-page":"1","volume":"2020","author":"J Oxenberg","year":"2020","unstructured":"Oxenberg J, Erchinger T, Chu K, Dove J, Protyniak B, Gupta A, Bannon J. A comparison of treatments and outcomes for medullary versus nonmedullary colon cancer: a single institutional experience showing a worse prognosis for stage 3 disease. Surgery research and practice. 2020;2020(2020):1\u20135.","journal-title":"Surgery research and practice"},{"issue":"3","key":"1304_CR21","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5114\/pg.2016.64740","volume":"12","author":"MA G\u00f3mez-\u00c1lvarez","year":"2017","unstructured":"G\u00f3mez-\u00c1lvarez MA, Lino-Silva LS, Salcedo-Hern\u00e1ndez RA, Padilla-Rosciano A, Ruiz-Garc\u00eda EB, L\u00f3pez-Basave HN, Calderillo-Ruiz G, Aguilar-Romero JM, Dom\u00ednguez-Rodr\u00edguez JA, Herrera-G\u00f3mez \u00c1, Meneses-Garc\u00eda A. Medullary colonic carcinoma with microsatellite instability has lower survival compared with conventional colonic adenocarcinoma with microsatellite instability. Gastroenterol Rev. 2017;12(3):208\u201314.","journal-title":"Gastroenterol Rev"},{"issue":"24","key":"1304_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249680","volume":"21","author":"L Laghi","year":"2020","unstructured":"Laghi L, Negri F, Gaiani F, Cavalleri T, Grizzi F, De\u2019 Angelis GL, Malesci A. Prognostic and predictive cross-roads of microsatellite instability and immune response to colon cancer. Int J Mol Sci. 2020;21(24): 9680.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1304_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1245\/s10434-023-14443-x","volume":"31","author":"CG Tran","year":"2024","unstructured":"Tran CG, Goffredo P, Mott SL, Suraju MO, Kohn JF, Mishra A, Vauthey J, Hassan I. Conditional overall survival after diagnosis of non-metastatic colon cancer: impact of laterality, MSI, and KRAS status. Ann Surg Oncol. 2024;31(1):142\u201351.","journal-title":"Ann Surg Oncol"},{"issue":"23","key":"1304_CR24","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9 T, Shiu K, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, van Cutsem E, Yang P, Farooqui MZH, Marinello P, Diaz LA. Pembrolizumab in microsatellite-instability\u2013high advanced colorectal cancer. N Engl J Med. 2020;383(23):2207\u201318.","journal-title":"N Engl J Med"},{"issue":"3","key":"1304_CR25","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1158\/1078-0432.CCR-11-2246","volume":"18","author":"S Ogino","year":"2012","unstructured":"Ogino S, Shima K, Meyerhardt JA, McCleary NJ, Ng K, Hollis D, Saltz LB, Mayer RJ, Schaefer P, Whittom R, Hantel A, Benson AB, Spiegelman D, Goldberg RM, Bertagnolli MM, Fuchs CS. Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803. Clin Cancer Res. 2012;18(3):890\u2013900.","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01304-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01304-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01304-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:15:28Z","timestamp":1757625328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01304-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1304"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01304-x","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"type":"print","value":"1941-6628"},{"type":"electronic","value":"1941-6636"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"16 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Verbal consent was obtained from the patient to publish this report and was documented in our hospital records accordingly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"185"}}